Profit: Gene therapy for intervertebral disc degeneration (Q3301670): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Added qualifier: readability score (P590521): 0.000011549083729174788) |
||||||
Property / summary: None (English) / qualifier | |||||||
readability score: 0.000011549083729174788
|
Latest revision as of 14:50, 12 March 2024
Project Q3301670 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | Profit: Gene therapy for intervertebral disc degeneration |
Project Q3301670 in Germany |
Statements
999,126.65 Euro
0 references
1,248,908.31 Euro
0 references
80.0 percent
0 references
1 December 2019
0 references
30 June 2022
0 references
Genequine Biotherapeutics GmbH
0 references
Luckenwalde, Stadt
0 references
16 February 2024
0 references
Identifiers
DE_TEMPORARY_4472
0 references